Propanc Biopharma, Inc. (PPCB)
NASDAQ: PPCB · Real-Time Price · USD
1.720
-0.050 (-2.82%)
Jun 3, 2026, 12:21 PM EDT - Market open
Propanc Biopharma Market Cap
Propanc Biopharma has a market cap or net worth of $1.44 million as of June 3, 2026. Its market cap has decreased by -97.64% in one year.
Market Cap
1.44M
Enterprise Value
1.48M
1-Year Change
-97.64%
Ranking
Category
Stock Price
$1.72
Market Cap Chart
Since February 10, 2023, Propanc Biopharma's market cap has increased from $571.43K to $1.44M, an increase of 151.64%. That is a compound annual growth rate of 32.16%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 2, 2026 | 1.48M | -79.37% |
| Dec 31, 2025 | 7.17M | 4,231.28% |
| Dec 31, 2024 | 165.57K | -48.84% |
| Dec 29, 2023 | 323.62K | -43.37% |
| Feb 10, 2023 | 571.43K | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Calidi Biotherapeutics | 2.82M |
| Oragenics | 2.73M |
| Ensysce Biosciences | 2.60M |
| Bone Biologics | 2.30M |
| Valion Bio | 2.18M |
| Biodexa Pharmaceuticals | 2.15M |
| Silexion Therapeutics | 2.09M |
| Scinai Immunotherapeutics | 1.98M |